drugset / Trial / NCT06218771
A Study of TQB3454 Tablets in Patients With Blood Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to evaluate the safety of TQB3454 tablets in patients with acute myeloid leukemia and myelodysplastic syndrome, and determine the phase II recommended dose.
Timeline
- Start
- 2023-07-10
- Primary completion
- 2025-06
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TQB3454 | Small molecule | — | Oral |